NCT02317887View on ClinicalTrials.gov

Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 11, 2015

Primary Completion Date

April 25, 2024

Study Completion Date

October 16, 2024

Conditions
RetinoschisisX-Linked
Interventions
BIOLOGICAL

RS1 AAV Vector

Gene transfer by intravitreal injection of the RS1 AAV vector (AAV8-scRS/IRBPhRS)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

VegaVect, Inc.

INDUSTRY

NCT02317887 - Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis | Biotech Hunter | Biotech Hunter